Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects

Metabolism: Clinical and Experimental

Volumn 48, Issue 5, 1999, Pages 655-657

  Hayakawa, Tetsuo ^a   Nagai, Yukihiro ^b   Nohara, Erika ^b   Yamashita, Haruhisa ^b   Takamura, Toshinari ^b   Abe, Toshio ^b   Nomura, Gakuji ^b   Kobayashi, Ken Ichi ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 2; INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032894790     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90067-7     Document Type: Article

References (19)

1. Randle PJ, Garland PB, Hales CN, et al: The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
2. Cohn SM, Simon TC, Roth KA, et al: Use of transgenic mice to map cis-acting elements in the intestinal fatty acid binding protein gene (Fabpi) that control its cell lineage-specific and regional patterns of expression along the duodenal-colonic and crypt-villus axes of the gut epithelium. J Cell Biol 119:27-44, 1992
3. Lowe JB, Sacchettini JC, Laposata M, et al: Expression of rat intestinal fatty acid-binding protein in Escherichia coli. J Biol Chem 262:5931-5937, 1987
4. Baier LJ, Sacchettini JC, Knowler WC, et al: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95:1281-1287, 1995
5. Hegele RA, Harris SB, Hanley AJG, et al: Genetic variation of intestinal fatty acid-binding protein associated with variation in body mass in aboriginal Canadians. J Clin Endocrinol Metab 81:4334-4337, 1996
6. Rissanen J, Pihlajamaki J, Heikkinen S, et al: The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects. Diabetes 46:711-712, 1997
7. Yamada K, Yuan X, Ishiyama S, et al: Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40:706-710, 1997
8. Mochizuki H, Egusa G, Okubo M, et al: No association of intestinal fatty acid binding protein polymorphism with insulin resistance in Japanese. Diabetologia 40:A173, 1997 (abstr)
9. Matthews DR, Hosker JP, Rudenski AS. et al: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
10. Prochazka M, Lillioja S, Tait JF, et al: Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians. Diabetes 42:514-519, 1993
11. Mitchell BD, Kammerer CM, O'Connell P, et al: Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans. Diabetes 44:1046-1053, 1995
12. Humphreys P, McCarthy M, Tuomilehto J, et al: Chromosome 4q locus associated with insulin resistance in Pima Indians: Studies in three European NIDDM populations. Diabetes 43:800-804, 1994
13. Elbein SC, Chiu KC, Hoffman MD, et al: Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes 44:1259-1265, 1995
14. Stern MP, Mitchell BD, Blangero J, et al: Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes 45:563-568, 1996
15. Vionnet N, Hani EH, Lesage S, et al: Genetics of NIDDM in France. Studies with 19 candidate genes in affected sib pairs. Diabetes 46:1062-1068, 1997
16. Yagi T, Nishi S, Hinata S, et al: A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein C-II) with type 2 diabetes and impaired glucose tolerance in Japanese subjects. Diabet Med 13:902-907, 1996
17. Baier LJ, Bogardus C, Sacchettini JC: A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells J Biol Chem 271:10892-10896, 1996
18. Sipiläinen R. Uusitupa M, Heikkinen S, et al: Variants in the human intestinal fatty acid binding protein 2 gene in obese subjects. J Clin Endocrinol Metab 82:2629-2632, 1997
19. Vidgren HM, Sipiläinen RH, Heikkinen S, et al: Threonine allele in codon 54 of the fatty acid binding protein 2 gene does not modify the fatty acid composition of serum lipids in obese subjects. Eur J Clin Invest 27:405-408, 1997